|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07H 21/04 | |
| A61K 39/395 | |||
| C07K 16/00 | |||
| C12N 15/63 | |||
| G01N 33/53 |
| (11) | Patento numeris | 1448584 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02761818.0 |
| Europos patento paraiškos padavimo data | 2002-09-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-08-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-05-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2002/030316 |
| Data | 2002-09-25 |
| (87) | Numeris | WO 2003/027135 |
| Data | 2003-04-03 |
| (30) | Numeris | Data | Šalis |
| 325360 P | 2001-09-26 | US |
| (72) |
PASTAN, Ira, H., US
SALVATORE, Giuliana, IT
BEERS, Richard, US
KREITMAN, Robert, J., US
|
| (73) |
The Government of the United States of America as represented by The Secretary of Health and Human Services,
Office of Technology Transfer, 6011 Executive Boulevard, Suite No. 325, Rockville, MD 20854,
US
|
| (54) | MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS |
| MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS |